{"id":106977,"date":"2024-03-06T18:24:00","date_gmt":"2024-03-06T11:24:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/20240306182400106977"},"modified":"2024-03-07T00:23:33","modified_gmt":"2024-03-06T16:23:33","slug":"%e7%bb%b4%e4%ba%9a%e7%94%9f%e7%89%a9%e6%8a%95%e8%b5%84%e5%ad%b5%e5%8c%96%e5%85%ac%e5%8f%b8%e8%bf%91%e6%9c%9f%e5%8f%91%e5%b1%95%e5%8a%a8%e6%80%81%e4%b8%80%e8%a7%88","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/20240306182400106977","title":{"rendered":"\u7ef4\u4e9a\u751f\u7269\u6295\u8d44\u5b75\u5316\u516c\u53f8\u8fd1\u671f\u53d1\u5c55\u52a8\u6001\u4e00\u89c8"},"content":{"rendered":"<p><p><span class=\"legendSpanClass\">\u9999\u6e2f<\/span><span class=\"legendSpanClass\">2024\u5e743\u67086\u65e5<\/span> \/\u7f8e\u901a\u793e\/ &#8212; \u9762\u5bf9\u4e0d\u65ad\u53d8\u5316\u7684\u5c40\u52bf\uff0c\u6280\u672f\u521b\u65b0\u4f9d\u65e7\u662f\u751f\u7269\u533b\u836f\u4f01\u4e1a\u957f\u8fdc\u53d1\u5c55\u6c38\u6052\u7684\u4e3b\u65cb\u5f8b\uff0c\u4e3a\u4f01\u4e1a\u6e90\u6e90\u4e0d\u65ad\u5730\u6ce8\u5165\u751f\u547d\u529b\uff0c\u6301\u7eed\u63a8\u52a8\u7814\u53d1&quot;\u4ece0\u52301&quot;\u8f6c\u5316\u4ee5\u53ca\u5546\u4e1a\u5316\u6210\u529f\u3002\u8fd1\u671f\uff0c\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u4f01\u4e1a\u53c8\u6709\u65b0\u7684\u52a8\u6001\uff1aAceLink\u3001\u7279\u79d1\u7f57\u7814\u53d1\u8fdb\u5c55\u987a\u5229\uff1b\u535a\u81f4\u751f\u7269\u3001Basking\u3001\u7279\u79d1\u7f57\u3001\u8f90\u8054\u79d1\u6280\u6210\u529f\u5b8c\u6210\u878d\u8d44\uff1b\u7ef4\u7738\u751f\u7269\u65a9\u83b7\u6b8a\u8363\uff1bAbsci\u8fbe\u6210\u91cd\u8981\u5408\u4f5c\u3002<\/p>\n<p><b>\u535a\u81f4\u751f\u7269\u5b8c\u62101800\u4e07\u7f8e\u5143A\u8f6e\u878d\u8d44<\/b><\/p>\n<p>\u8fd1\u65e5\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u535a\u81f4\u751f\u7269\uff08Proviva Therapeutics\uff09\u6b23\u7136\u5ba3\u5e03\u5b8c\u62101800\u4e07\u7f8e\u5143\u7684A\u8f6e\u878d\u8d44\uff0c\u4ee5\u63a8\u8fdb\u5176\u6838\u5fc3\u4ea7\u54c1PTX-912\u7684\u4e34\u5e8a\u5f00\u53d1\u3002\u9f99\u78d0\u6295\u8d44\uff0c\u6069\u7136\u521b\u6295\u548c\u4ed9\u77b3\u8d44\u672c\u8054\u5408\u53c2\u52a0\u672c\u8f6e\u878d\u8d44\u3002<\/p>\n<p>\u535a\u81f4\u751f\u7269\u662f\u4e00\u5bb6\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u81f4\u529b\u4e8e\u5f00\u53d1\u65b0\u4e00\u4ee3\u7ec6\u80de\u56e0\u5b50\u6297\u80bf\u7624\u514d\u75ab\u7597\u6cd5\u3002\u9488\u5bf9\u7ec6\u80de\u56e0\u5b50\u5916\u5468\u6bd2\u6027\u7684\u4f20\u7edf\u96be\u9898\uff0c\u516c\u53f8\u81ea\u4e3b\u5f00\u53d1\u4e86&quot;Crossover&quot;\u7ec6\u80de\u56e0\u5b50\u524d\u836f\u6280\u672f\u5e73\u53f0\uff0c\u5b9e\u73b0\u5728\u80bf\u7624\u5fae\u73af\u5883\u4e2d\u7279\u5f02\u6027\u7684\u836f\u7269\u6d3b\u6027\u91ca\u653e\u3002\u4f9d\u6258&quot;Crossover&quot;\u6280\u672f\u5e73\u53f0\uff0c\u535a\u81f4\u6210\u529f\u7814\u53d1\u51faPTX-912\u2014\u2014\u65b0\u4e00\u4ee3\u514d\u75ab\u7ec6\u80de\u9776\u5411\u7684\u767d\u7ec6\u80de\u4ecb\u7d20-2\uff08IL-2\uff09\u524d\u836f\u878d\u5408\u86cb\u767d\u3002<\/p>\n<p><b>AceLink Therapeutics\u53d1\u5e03\u5065\u5eb7\u5fd7\u613f\u8005\u53c2\u4e0e\u8bc4\u4f30AL01211\u7684I\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6570\u636e<\/b><\/p>\n<p>\u7ebd\u74e6\u514b\uff0c\u52a0\u5229\u798f\u5c3c\u4e9a\u5dde\u2014\u20142024\u5e742\u670826\u65e5\uff0cAceLink Therapeutics\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u5f00\u53d1\u4e0b\u4e00\u4ee3\u53e3\u670d\u5e95\u7269\u51cf\u5c11\u7597\u6cd5\uff08SRTs\uff09\u7684\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8\u5ba3\u5e03\uff0c\u5176\u5728\u5065\u5eb7\u5fd7\u613f\u8005\u4e2d\u8fdb\u884c\u7684AL01211\u7684I\u671f\u7814\u7a76\u7684\u7ed3\u679c\u5df2\u7ecf\u53d1\u8868\u5728\u540c\u884c\u8bc4\u5ba1\u7684\u7f8e\u56fd\u4e34\u5e8a\u836f\u5b66\u9662\u671f\u520a\u300aClinical Pharmacology in Drug Development\u300b\u4e0a\u3002AL01211\u662f\u4e00\u79cd\u5f3a\u5927\u7684\u53e3\u670d\u8461\u7cd6\u795e\u7ecf\u9170\u80fa\u5408\u6210\u9176\uff08GCS\uff09\u6291\u5236\u5242\uff0c\u6b63\u5728\u5f00\u53d1\u7528\u4e8e\u6cbb\u7597\u6cd5\u5e03\u91cc\u75c5\u548cI\u578b\u6208\u8c22\u75c5\u3002<\/p>\n<p>\u5728\u5df2\u53d1\u8868\u7684I\u671f\u7814\u7a76\u4e2d\uff0c\u5bf9AL01211\u8fdb\u884c\u4e86\u5355\u5242\u91cf\u9012\u589e\u548c\u591a\u5242\u91cf\u9012\u589e\u7684\u7814\u7a76\uff0c\u4ee5\u786e\u5b9a\u5176\u5728\u5065\u5eb7\u5fd7\u613f\u8005\u4e2d\u7684\u5b89\u5168\u6027\u3001\u836f\u4ee3\u52a8\u529b\u5b66\uff08PK\uff09\u548c\u836f\u6548\u5b66\uff08PD\uff09\u6548\u5e94\u3002\u603b\u4f53\u800c\u8a00\uff0cAL01211\u5177\u6709\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\uff0c\u65e0\u4e25\u91cd\u4e0d\u826f\u4e8b\u4ef6\u3002\u572830mg\u5242\u91cf\u6c34\u5e73\u4e0b\uff0c\u8840\u6d46\u8461\u7cd6\u57fa\u795e\u7ecf\u9170\u80fa\u548c\u7403\u86cb\u767d\u4e09\u7cd6\u795e\u7ecf\u9170\u80fa\u5206\u522b\u4ece\u57fa\u7ebf\u6c34\u5e73\u964d\u4f4e\u4e8678%\u548c52%\uff0c\u4ece\u800c\u652f\u6301AL01211\u7684\u8fdb\u4e00\u6b65\u4e34\u5e8a\u7814\u7a76\u3002<\/p>\n<p><b>Basking\u5ba3\u5e03\u5b8c\u6210\u7531ARCH\u9886\u6295\u76845500\u4e07\u7f8e\u5143\u878d\u8d44\uff0c\u52a0\u901f\u53ef\u9006\u6eb6\u6813\u5242\u7684\u4e34\u5e8a\u5f00\u53d1<\/b><\/p>\n<p>\u4fc4\u4ea5\u4fc4\u5dde\u54e5\u4f26\u5e03\u2014\u20142024\u5e741\u670830\u65e5\uff0cBasking Biosciences\uff08\u4ee5\u4e0b\u7b80\u79f0&quot;Basking&quot;\uff09\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\uff0c\u4e00\u5bb6\u5f00\u53d1\u65b0\u578b\u6025\u6027\u6eb6\u6813\u7597\u6cd5\u6cbb\u7597\u5352\u4e2d\u7684\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8\uff0c\u5ba3\u5e03\u5b8c\u62105500\u4e07\u7f8e\u5143\u7684\u878d\u8d44\u3002\u65b0\u6295\u8d44\u8005ARCH Venture Partners\u9886\u6295\uff0c\u5176\u4ed6\u65b0\u6295\u8d44\u8005Insight Partners\u3001Platanus\u3001Solas BioVentures\u548cRTW Investments\uff0c\u4ee5\u53ca\u73b0\u6709\u6295\u8d44\u8005\u8ddf\u6295\u3002ARCH Venture Partners\u8463\u4e8b\u603b\u7ecf\u7406Steven Gillis\u535a\u58eb\u5c06\u62c5\u4efbBasking\u8463\u4e8b\u4f1a\u4e3b\u5e2d\u3002\u6b64\u524d\u516c\u53f8\u66fe\u5b8c\u6210540\u4e07\u7f8e\u5143\u79cd\u5b50\u8f6e\u878d\u8d44\uff0c\u6295\u8d44\u8005\u5305\u62ecRev1 Ventures\u3001Broadview Ventures\u548c\u7ef4\u4e9a\u751f\u7269\u3002<\/p>\n<p>Basking\u5c06\u5229\u7528\u878d\u8d44\u52a0\u901fBB-031\u7684\u4e34\u5e8a\u5f00\u53d1\u3002\u8fd9\u662f\u4e00\u79cd\u9776\u5411von Willebrand\u56e0\u5b50\uff08vWF\uff09\u7684\u540c\u7c7b\u9996\u521b\u53ef\u9006RNA aptamers\uff0c\u4e13\u4e3a\u5feb\u901f\u8d77\u6548\u548c\u77ed\u6301\u7eed\u65f6\u95f4\u7684\u7597\u6548\u800c\u8bbe\u8ba1\u3002<\/p>\n<p><b>\u7279\u79d1\u7f57\u83b7\u4e07\u7269\u521b\u6295\u6570\u767e\u4e07\u7f8e\u5143Pre-B\u8f6e\u878d\u8d44\uff0c\u4e14\u5176\u6cbb\u7597\u96c4\u6fc0\u7d20\u6027\u8131\u53d1\u5168\u7403\u9996\u521b\u65b0\u836fTDM-105795\u4e34\u5e8a\u4e8c\u671fa\u8bd5\u9a8c\u987a\u5229\u5b8c\u6210\u53ca\u5b8c\u6210\u9488\u5bf9\u6e7f\u75b9\/\u76ae\u708e\u9002\u5e94\u75c7\u7684TDM-180935\u5242\u91cf\u9012\u589e\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c<\/b><\/p>\n<p>\u636e\u52a8\u8109\u7f511\u670815\u65e5\u6d88\u606f\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u4e13\u6ce8\u76ae\u80a4\u75be\u75c5\u65b0\u836f\u7814\u53d1\u7684\u4e34\u5e8a\u9636\u6bb5\u516c\u53f8\u7279\u79d1\u7f57\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7b80\u79f0&quot;\u7279\u79d1\u7f57&quot;\uff09\uff0c\u5ba3\u5e03\u5df2\u4e8e\u8fd1\u671f\u5b8c\u6210\u6570\u5343\u4e07\u4eba\u6c11\u5e01\u7684Pre-B\u8f6e\u878d\u8d44\uff0c\u672c\u8f6e\u878d\u8d44\u6295\u8d44\u65b9\u4e3a\u4e07\u7269\u521b\u6295\uff0c\u6240\u878d\u8d44\u91d1\u5c06\u7528\u4e8e\u6bdb\u53d1\u9879\u76ee\u7684\u540e\u7eed\u4e34\u5e8a\u5f00\u53d1\u548c\u6e7f\u75b9\u76ae\u708e\u9879\u76ee\u4e2d\u7f8e\u53cc\u62a5\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff08\u4e2d\u7f8eIIa\u4e34\u5e8a\uff09\u3002\u968f\u540e2\u67085\u65e5\uff0c\u7279\u79d1\u7f57\u5f88\u9ad8\u5174\u5730\u5ba3\u5e03\uff1a\u5916\u7528\u6d82\u62b9\u5236\u5242TDM-105795\u7528\u4e8e\u6cbb\u7597\u96c4\u6fc0\u7d20\u6027\u8131\u53d1\uff08AGA\uff09\u7684\u9996\u4e2a\u4e34\u5e8a\u4e8c\u671f\u8bd5\u9a8c\uff08NCT05802173\uff09\u987a\u5229\u5b8c\u6210\u3002<\/p>\n<p>\u6b64\u5916\uff0c2023\u5e7412\u67084\u65e5\uff0c\u7279\u79d1\u7f57\u5ba3\u5e03\u5df2\u7ecf\u5b8c\u6210\u9488\u5bf9\u7279\u5e94\u6027\u76ae\u708e\/\u6e7f\u75b9\u7684TDM-180935\u5916\u7528\u8f6f\u818f\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff08NCT05525468\uff09\uff0c\u8bd5\u9a8c\u7ed3\u679c\u5747\u8fbe\u5230\u9884\u671f\u3002<\/p>\n<p><b>\u8f90\u8054\u79d1\u6280\u5ba3\u5e03\u5b8c\u6210B\u8f6e\u7f8e\u5143\u878d\u8d44\uff0c\u4e14\u5176\u6bd4\u5229\u65f6GMP\u751f\u4ea7\u8bbe\u65bd\u5960\u57fa<\/b><\/p>\n<p>2024\u5e741\u67084\u65e5\uff0c\u4e0a\u6d77\/\u8ba9\u5e03\u5362\/\u6d77\u5fb7\u5821\u2014\u2014\u7ef4\u4e9a\u751f\u7269\u88ab\u6295\u4f01\u4e1a\u3001\u5168\u9762\u6574\u5408\u7684\u56fd\u9645\u5316\u653e\u5c04\u6027\u836f\u7269\u6cbb\u7597\u516c\u53f8\u8f90\u8054\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7b80\u79f0&quot;\u8f90\u8054\u79d1\u6280&quot;\uff09\uff0c\u5ba3\u5e03\u5b8c\u62106330\u4e07\u7f8e\u5143\u878d\u8d44\uff0c\u5176\u4e2d\u5305\u62ec4730\u4e07\u7f8e\u5143\u7684B\u8f6e\u80a1\u6743\u878d\u8d44\u548c1600\u4e07\u7f8e\u5143\u7684\u6388\u4fe1\u989d\u5ea6\u3002\u672c\u6b21\u878d\u8d44\u5c06\u5e2e\u52a9\u516c\u53f8\u5feb\u901f\u63a8\u8fdb\u5176\u653e\u5c04\u6027\u836f\u7269\u7ba1\u7ebf\u7684\u5f00\u53d1\u548c\u836f\u7269\u751f\u4ea7\u80fd\u529b\u7684\u5efa\u8bbe\uff0c\u5e76\u4f18\u5316\u5176\u4e13\u6709\u53d1\u73b0\u5e73\u53f0UniRDC&#x2122;\u3002 \u968f\u7740\u672c\u6b21\u878d\u8d44\u7684\u5b8c\u6210\uff0c\u8f90\u8054\u79d1\u6280\u81ea2021\u5e748\u6708\u6210\u7acb\u4ee5\u6765\u5df2\u7d2f\u8ba1\u878d\u8d44\u8d85\u8fc71.1\u4ebf\u7f8e\u5143\uff0c\u5305\u62ec\u80a1\u6743\u878d\u8d44\u3001\u503a\u6743\u878d\u8d44\u548c\u653f\u5e9c\u8865\u8d34\u3002<\/p>\n<p>\u6b64\u524d12\u67088\u65e5\uff0c\u8f90\u8054\u79d1\u6280\u8fd8\u5ba3\u5e03\u4e86\u5728\u6bd4\u5229\u65f6\u8ba9\u5e03\u5362\u5e02\u5f00\u5de5\u5efa\u8bbe\u5176\u7b26\u5408\u751f\u4ea7\u8d28\u91cf\u7ba1\u7406\u89c4\u8303\uff08&quot;GMP&quot;\uff09\u7684\u653e\u5c04\u6027\u836f\u7269\u751f\u4ea7\u8bbe\u65bd\uff0c\u4ee5\u8fdb\u4e00\u6b65\u63a8\u8fdb\u653e\u5c04\u6027\u836f\u7269\u7684\u5168\u4ea7\u4e1a\u94fe\u89e3\u51b3\u65b9\u6848\u3002<\/p>\n<p><b>\u7ef4\u7738\u751f\u7269\u83b7\u9999\u6e2f\u521b\u65b0\u79d1\u6280\u7f72&quot;\u4f01\u4e1a\u652f\u63f4\u8ba1\u5212&quot;\u8d44\u52a9\uff0c\u4e14\u8363\u767b\u300a2023\u80e1\u6da6\u5168\u7403\u730e\u8c79\u4f01\u4e1a\u699c\u300b<\/b><\/p>\n<p>\u8fd1\u671f\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u7ef4\u7738\u751f\u7269\u7684\u9999\u6e2f\u5b50\u516c\u53f8\uff0c\u4e00\u5bb6\u805a\u7126\u5dee\u5f02\u5316\u548c\u5168\u7403\u65b0\u5f00\u53d1\u7684\u773c\u79d1\u521b\u65b0\u836f\u516c\u53f8\uff0c\u5ba3\u5e03\u5176\u521b\u65b0\u773c\u5e95\u836f\u7269VVN481\u6210\u529f\u83b7\u5f97\u9999\u6e2f\u521b\u65b0\u79d1\u6280\u7f72&quot;\u4f01\u4e1a\u652f\u63f4\u8ba1\u5212Enterprise Support Scheme&quot;(ESS\u2014Hong Kong-Israel R&amp;D Cooperation Programme) \u8d44\u52a9\u3002\u6b64\u6b21\u8d44\u52a9\u5c06\u7528\u4e8e\u63a8\u8fdb\u8be5\u7ba1\u7ebf\u7684\u4e34\u5e8a\u524d\u7814\u53d1\u5de5\u4f5c\uff0c\u4ee5\u671f\u66f4\u5feb\u63a8\u8fdb\u5230\u4e34\u5e8a\u9636\u6bb5\u3002\u6b64\u5916\uff0c\u8fd1\u65e5\u7ef4\u7738\u751f\u7269\u8fd8\u8363\u767b\u300a2023\u80e1\u6da6\u5168\u7403\u730e\u8c79\u4f01\u4e1a\u699c\u300b\u3002<\/p>\n<p><b>\u7ef4\u4e9a\u751f\u7269\u88ab\u6295\u4f01\u4e1aAbsci\u5ba3\u5e03\u4e0e\u963f\u65af\u5229\u5eb7\u5408\u4f5c\u5f00\u53d1\u4eba\u5de5\u667a\u80fd\u9a71\u52a8\u7684\u80bf\u7624\u5019\u9009\u836f\u7269<\/b><\/p>\n<p>\u534e\u76db\u987f\u5dde\u6e29\u54e5\u534e\uff0c2023\u5e7412\u67084\u65e5\u2014\u2014\u7ef4\u4e9a\u751f\u7269\u88ab\u6295\u4f01\u4e1a\u3001\u751f\u6210\u5f0f\u4eba\u5de5\u667a\u80fd\u6297\u4f53\u53d1\u73b0\u9886\u57df\u7684\u9886\u5bfc\u8005Absci\u516c\u53f8\uff08NASDAQ:ABSI\uff09\uff0c\u5ba3\u5e03\u4e0e\u5168\u7403\u751f\u7269\u5236\u836f\u516c\u53f8\u963f\u65af\u5229\u5eb7\uff08AstraZeneca\uff09\u5408\u4f5c\uff0c\u9488\u5bf9\u80bf\u7624\u9776\u70b9\u63d0\u4f9b\u4eba\u5de5\u667a\u80fd\u8bbe\u8ba1\u7684\u6297\u4f53\u3002\u6b64\u6b21\u5408\u4f5c\u5c06Absci\u7684Integrated Drug Creation&#x2122;\u5e73\u53f0\u4e0e\u963f\u65af\u5229\u5eb7\u5728\u80bf\u7624\u5b66\u9886\u57df\u7684\u4e13\u4e1a\u77e5\u8bc6\u76f8\u7ed3\u5408\uff0c\u65e8\u5728\u52a0\u901f\u53d1\u73b0\u6f5c\u5728\u7684\u65b0\u578b\u764c\u75c7\u6cbb\u7597\u5019\u9009\u836f\u7269\u3002\u636e\u6089\uff0c\u8be5\u534f\u8bae\u5305\u62ec\u9884\u4ed8\u6b3e\u3001\u7814\u53d1\u7ecf\u8d39\u548c\u91cc\u7a0b\u7891\u6b3e\u9879\u7b49\uff0c\u603b\u91d1\u989d\u9ad8\u8fbe2.47\u4ebf\u7f8e\u5143\u3002<\/p>\n<p><b>\u5173\u4e8e\u535a\u81f4\u751f\u7269<\/b><\/p>\n<p>\u535a\u81f4\u751f\u7269\u521b\u7acb\u4e8e2019\u5e74\uff0c\u7531\u86cb\u767d\u8d28\u5de5\u7a0b\u548c\u80bf\u7624\u514d\u75ab\u9886\u57df\u7684\u9876\u5c16\u4e13\u5bb6\u56e2\u961f\u7ec4\u5efa\uff0c\u81f4\u529b\u4e8e\u5f00\u53d1\u65b0\u4e00\u4ee3\u7ec6\u80de\u56e0\u5b50\u6297\u80bf\u7624\u514d\u75ab\u7597\u6cd5\u3002\u516c\u53f8\u81ea\u4e3b\u7814\u53d1\u4e86&quot;Crossover&quot;\u524d\u836f\u6280\u672f\u5e73\u53f0\uff0c\u80fd\u5b9e\u73b0\u7ec6\u80de\u56e0\u5b50\u5728\u80bf\u7624\u5fae\u73af\u5883\u4e2d\u7279\u5f02\u6027\u91ca\u653e\uff0c\u6709\u6548\u89e3\u51b3\u4e86\u7ec6\u80de\u56e0\u5b50\u7684\u5916\u5468\u6bd2\u6027\u95ee\u9898\u3002\u4f9d\u6258\u8be5\u5e73\u53f0\u6280\u672f\uff0c\u516c\u53f8\u6210\u529f\u5f00\u53d1\u4e86\u4e34\u5e8a\u5019\u9009\u836f\u7269PTX-912\uff0c\u5df2\u7ecf\u542f\u52a8\u7f8e\u56fd1\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<p><b>\u5173\u4e8eAceLink Therapeutics<\/b><\/p>\n<p>AceLink Therapeutics\u6210\u7acb\u4e8e2018\u5e74\uff0c\u662f\u4e00\u5bb6\u521b\u65b0\u578b\u751f\u7269\u5236\u836f\u521d\u521b\u516c\u53f8\uff0c\u4e13\u6ce8\u4e8e\u5f00\u53d1\u5b89\u5168\u6709\u6548\u7684\u836f\u7269\uff0c\u4ee5\u6ee1\u8db3\u5b58\u5728\u9ad8\u5ea6\u672a\u6ee1\u8db3\u7684\u4e34\u5e8a\u9700\u6c42\u7684\u9057\u4f20\u6027\u75be\u75c5\u3002\u516c\u53f8\u6700\u521d\u7684\u91cd\u70b9\u662f\u5f00\u53d1\u6cd5\u5e03\u91cc\u75c5\u7684\u65b0\u578b\u6cbb\u7597\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee <a href=\"http:\/\/www.acelinktherapeutics.com\" rel=\"nofollow\">www.acelinktherapeutics.com<\/a><\/p>\n<p><b>\u5173\u4e8eBasking Biosciences<\/b><\/p>\n<p>Basking Biosciences\u662f\u4e00\u5bb6\u5904\u4e8e\u4e34\u5e8a\u9636\u6bb5\u7684\u516c\u53f8\uff0c\u65e8\u5728\u89e3\u51b3\u7f3a\u8840\u6027\u8111\u5352\u4e2d\u6cbb\u7597\u7684\u6700\u5927\u9700\u6c42\u2014\u2014\u4e00\u79cd\u5feb\u901f\u8d77\u6548\u7684\u77ed\u6548\u6eb6\u6813\u836f\u7269\uff0c\u80fd\u591f\u63d0\u4f9b\u6bd4\u73b0\u6709\u7597\u6cd5\u5927\u5927\u5ef6\u957f\u7684\u6cbb\u7597\u7a97\u53e3\uff0c\u5e76\u91cd\u65b0\u758f\u901a\u963b\u585e\u7684\u52a8\u8109\uff0c\u5e76\u4e14\u5728\u51fa\u8840\u65f6\u53ef\u4ee5\u8fc5\u901f\u88ab\u9006\u8f6c\u6d3b\u6027\u3002\u516c\u53f8\u6b63\u5728\u5f00\u53d1\u7684\u836f\u7269BB-031\uff0c\u5373\u662f\u8fd9\u79cdfirst -in-class RNA\u9002\u914d\u4f53\uff0c\u9776\u5411\u8840\u6813\u7684\u91cd\u8981\u7ed3\u6784\u6210\u5206\u548c\u51dd\u8840\u8fc7\u7a0b\u7684\u9a71\u52a8\u56e0\u7d20\u8840\u7ba1\u6027\u8840\u53cb\u75c5\u56e0\u5b50\uff08von Willebrand Factor\uff0cvWF\uff09\u3002<\/p>\n<p><b>\u5173\u4e8e\u7279\u79d1\u7f57\u751f\u7269\u79d1\u6280(<\/b><b>\u6210\u90fd)<\/b><b>\u6709\u9650\u516c\u53f8 <\/b><\/p>\n<p>\u7279\u79d1\u7f57\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\u662f\u4e00\u5bb6\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u533b\u836f\u516c\u53f8\u3002\u516c\u53f8\u524d\u8eab\u4e3a\u5609\u5174\u7279\u79d1\u7f57\u751f\u7269\u79d1\u6280\u6709\u9650\u516c\u53f8\uff0c\u65b0\u8fd1\u4e8e2023\u5e743\u6708\u642c\u8fc1\u81f3\u56db\u5ddd\u7701\u6210\u90fd\u5929\u5e9c\u56fd\u9645\u751f\u7269\u57ce\u3002<\/p>\n<p>\u516c\u53f8\u76ee\u524d\u7684\u6838\u5fc3\u7814\u53d1\u9879\u76ee\u5305\u62ec\u9488\u5bf9\u6cbb\u7597\u96c4\u6fc0\u7d20\u6027\u8131\u53d1\u3001\u7279\u5e94\u6027\u76ae\u708e\/\u6e7f\u75b9\u3001\u94f6\u5c51\u75c5\u548c\u7ea2\u6591\u72fc\u75ae\u7b49\u75be\u75c5\u7684\u521b\u65b0\u836f\u7269\u3002\u516c\u53f8\u5168\u7403\u9886\u5148\u7684\u6cbb\u7597\u96c4\u6fc0\u7d20\u6027\u8131\u53d1\u7684\u5c0f\u5206\u5b50\u5019\u9009\u836f\u7269TDM-105795\u5373\u5c06\u5b8c\u6210\u4e8c\u671fa\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u9488\u5bf9\u7279\u5e94\u6027\u76ae\u708e\/\u6e7f\u75b9\u7684\u521b\u65b0\u578bJAK1\/TYK2\u6291\u5236\u5242\u4e5f\u5df2\u7ecf\u5b8c\u6210\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u5373\u5c06\u5f00\u5c55\u4e34\u5e8a\u4e8c\u671fPOC\u8bd5\u9a8c\u3002\u516c\u53f8\u5177\u6709\u591a\u4e2a\u4e34\u5e8a\u524d\u6216\u4e34\u5e8a\u9636\u6bb5\u7684\u5019\u9009\u836f\u7269\uff0c\u5728\u7814\u7ba1\u7ebf\u4ea7\u54c1\u90fd\u662f\u9488\u5bf9\u6cbb\u7597\u5404\u79cd\u76ae\u80a4\u9002\u5e94\u75c7\u3002<\/p>\n<p><b>\u5173\u4e8e\u8f90\u8054\u79d1\u6280<\/b><\/p>\n<p>\u8f90\u8054\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08&quot;\u8f90\u8054\u79d1\u6280&quot;\uff09\u662f\u4e00\u5bb6\u5168\u9762\u6574\u5408\u7684\u56fd\u9645\u5316\u653e\u5c04\u6027\u836f\u7269\u6cbb\u7597\u516c\u53f8\uff0c\u5728\u6bd4\u5229\u65f6\u3001\u5fb7\u56fd\u548c\u4e2d\u56fd\u5747\u8bbe\u6709\u529e\u4e8b\u5904\u3002\u6211\u4eec\u81f4\u529b\u4e8e\u6253\u9020\u62e5\u6709\u653e\u5c04\u6027\u836f\u7269\u7814\u53d1\u3001\u751f\u4ea7\u548c\u5546\u4e1a\u5316\u7684\u5168\u4ea7\u4e1a\u94fe\u7684\u6838\u836f\u516c\u53f8\u4ee5\u9020\u798f\u5168\u7403\u60a3\u8005\u3002\u6211\u4eec\u8ba1\u5212\u901a\u8fc7\u9488\u5bf9\u672a\u6765\u6cbb\u7597\u65b9\u6cd5\u7684\u521b\u65b0\u7814\u7a76\u6765\u89e3\u51b3\u76ee\u524d\u5f71\u54cd\u653e\u5c04\u6027\u836f\u7269\u7814\u53d1\u7684\u6838\u5fc3\u95ee\u9898\u3002\u6211\u4eec\u56e2\u961f\u4e2d\u4e0d\u4e4f\u7ecf\u9a8c\u4e30\u5bcc\u7684\u4f01\u4e1a\u5bb6\u548c\u79d1\u5b66\u5bb6\uff0c\u4ed6\u4eec\u65e2\u64c5\u957f\u7ba1\u7406\u751f\u7269\u533b\u836f\u516c\u53f8\uff0c\u4e5f\u6df1\u8c19\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u7684\u7814\u7a76\u548c\u4e34\u5e8a\u5f00\u53d1\u65b9\u6cd5\u3002<\/p>\n<p><b>\u5173\u4e8e\u7ef4\u7738\u751f\u7269<\/b><\/p>\n<p>\u7ef4\u7738\u751f\u7269\u662f\u4e00\u5bb6\u4e13\u6ce8\u4e8e\u773c\u79d1\u521b\u65b0\u836f\u7814\u53d1\u9886\u57df\u7684\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u62e5\u6709\u56fd\u9645\u4e00\u6d41\u7684\u773c\u79d1\u521b\u65b0\u836f\u7814\u53d1\u56e2\u961f\u548c\u6280\u672f\u5e73\u53f0\uff0c\u4f9d\u6258\u81ea\u4e3b\u7814\u53d1\u5df2\u7ecf\u5efa\u7acb\u8d77\u5177\u6709\u5168\u7403\u7ade\u4e89\u529b\u7684\u4ea7\u54c1\u7ba1\u7ebf\u3002\u9664VVN001\u9879\u76ee\u5916\uff0c\u7ef4\u7738\u751f\u7269\u6b63\u5728\u5f00\u53d1VVN539\u7528\u4e8e\u6cbb\u7597\u9752\u5149\u773c\u6216\u9ad8\u773c\u538b\u75c7\uff0cVVN461\u7528\u4e8e\u6cbb\u7597\u975e\u611f\u67d3\u6027\u524d\u8461\u8404\u819c\u708e\u548c\u672f\u540e\u708e\u75c7\u3002\u7ef4\u7738\u751f\u7269\u8fd8\u81f4\u529b\u4e8e\u53d1\u73b0\u548c\u5f00\u53d1\u7528\u4e8e\u6cbb\u7597\u5176\u4ed6\u524d\u3001\u540e\u773c\u75be\u75c5\u7684\u65b0\u7597\u6cd5\u3002<\/p>\n<p><b>\u5173\u4e8eAbsci<\/b><\/p>\n<p>Absci\u662f\u4e00\u5bb6\u751f\u6210\u578b\u4eba\u5de5\u667a\u80fd\u836f\u7269\u5f00\u53d1\u516c\u53f8\uff0c\u5c06\u4eba\u5de5\u667a\u80fd\u4e0e\u53ef\u6269\u5c55\u7684\u6e7f\u5b9e\u9a8c\u5ba4\u6280\u672f\u76f8\u7ed3\u5408\uff0c\u66f4\u5feb\u5730\u4e3a\u60a3\u8005\u521b\u9020\u66f4\u597d\u7684\u751f\u7269\u5236\u54c1\u3002\u5176Integrated Drug Creation&#x2122;\u5e73\u53f0\u901a\u8fc7\u540c\u65f6\u4f18\u5316\u517c\u5177\u5f00\u53d1\u548c\u6cbb\u7597\u6548\u679c\u7684\u591a\u79cd\u836f\u7269\u7279\u6027\uff0c\u91ca\u653e\u4e86\u52a0\u5feb\u836f\u7269\u4e0a\u5e02\u65f6\u95f4\u548c\u63d0\u9ad8\u6210\u529f\u6982\u7387\u7684\u6f5c\u529b\u3002\u901a\u8fc7\u6570\u636e\u5b66\u4e60\u3001\u4eba\u5de5\u667a\u80fd\u521b\u9020\u548c\u6e7f\u6cd5\u5b9e\u9a8c\u5ba4\u9a8c\u8bc1\uff0cAbsci \u6bcf\u5468\u53ef\u7b5b\u9009\u6570\u5341\u4ebf\u4e2a\u7ec6\u80de\uff0c\u4f7f\u5176\u80fd\u591f\u5728\u77ed\u77ed\u516d\u5468\u5185\u5b8c\u6210\u4ece\u4eba\u5de5\u667a\u80fd\u8bbe\u8ba1\u6297\u4f53\u5230\u6e7f\u6cd5\u5b9e\u9a8c\u5ba4\u9a8c\u8bc1\u5019\u9009\u836f\u7269\u7684\u8fc7\u7a0b\u3002Absci\u7684\u613f\u666f\u662f\u4e3a\u6bcf\u4e2a\u4eba\u4e00\u952e\u63d0\u4f9b\u7a81\u7834\u6027\u7684\u6cbb\u7597\u65b9\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95eewww.absci.com&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u9999\u6e2f2024\u5e743\u67086\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u9762\u5bf9\u4e0d\u65ad\u53d8\u5316\u7684\u5c40\u52bf\uff0c\u6280\u672f\u521b\u65b0\u4f9d\u65e7\u662f\u751f\u7269\u533b\u836f\u4f01\u4e1a\u957f\u8fdc\u53d1\u5c55\u6c38\u6052\u7684\u4e3b\u65cb\u5f8b\uff0c\u4e3a\u4f01\u4e1a\u6e90\u6e90\u4e0d\u65ad\u5730\u6ce8\u5165\u751f\u547d\u529b\uff0c\u6301\u7eed\u63a8\u52a8\u7814\u53d1&quot;\u4ece0\u52301&quot;\u8f6c\u5316\u4ee5\u53ca\u5546\u4e1a\u5316\u6210\u529f\u3002\u8fd1\u671f\uff0c\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u4f01\u4e1a\u53c8\u6709\u65b0\u7684\u52a8\u6001\uff1aAceLink\u3001\u7279\u79d1\u7f57\u7814\u53d1\u8fdb\u5c55\u987a\u5229\uff1b\u535a\u81f4\u751f\u7269\u3001Basking\u3001\u7279\u79d1\u7f57\u3001\u8f90\u8054\u79d1\u6280\u6210\u529f\u5b8c\u6210\u878d\u8d44\uff1b\u7ef4\u7738\u751f\u7269\u65a9\u83b7\u6b8a\u8363\uff1bAbsci\u8fbe\u6210\u91cd\u8981\u5408\u4f5c\u3002 \u535a\u81f4\u751f\u7269\u5b8c\u62101800\u4e07\u7f8e\u5143A\u8f6e\u878d\u8d44 \u8fd1\u65e5\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u535a\u81f4\u751f\u7269\uff08Proviva Therapeutics\uff09\u6b23\u7136\u5ba3\u5e03\u5b8c\u62101800\u4e07\u7f8e\u5143\u7684A\u8f6e\u878d\u8d44\uff0c\u4ee5\u63a8\u8fdb\u5176\u6838\u5fc3\u4ea7\u54c1PTX-912\u7684\u4e34\u5e8a\u5f00\u53d1\u3002\u9f99\u78d0\u6295\u8d44\uff0c\u6069\u7136\u521b\u6295\u548c\u4ed9\u77b3\u8d44\u672c\u8054\u5408\u53c2\u52a0\u672c\u8f6e\u878d\u8d44\u3002 \u535a\u81f4\u751f\u7269\u662f\u4e00\u5bb6\u4e34\u5e8a\u9636\u6bb5\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u81f4\u529b\u4e8e\u5f00\u53d1\u65b0\u4e00\u4ee3\u7ec6\u80de\u56e0\u5b50\u6297\u80bf\u7624\u514d\u75ab\u7597\u6cd5\u3002\u9488\u5bf9\u7ec6\u80de\u56e0\u5b50\u5916\u5468\u6bd2\u6027\u7684\u4f20\u7edf\u96be\u9898\uff0c\u516c\u53f8\u81ea\u4e3b\u5f00\u53d1\u4e86&quot;Crossover&quot;\u7ec6\u80de\u56e0\u5b50\u524d\u836f\u6280\u672f\u5e73\u53f0\uff0c\u5b9e\u73b0\u5728\u80bf\u7624\u5fae\u73af\u5883\u4e2d\u7279\u5f02\u6027\u7684\u836f\u7269\u6d3b\u6027\u91ca\u653e\u3002\u4f9d\u6258&quot;Crossover&quot;\u6280\u672f\u5e73\u53f0\uff0c\u535a\u81f4\u6210\u529f\u7814\u53d1\u51faPTX-912\u2014\u2014\u65b0\u4e00\u4ee3\u514d\u75ab\u7ec6\u80de\u9776\u5411\u7684\u767d\u7ec6\u80de\u4ecb\u7d20-2\uff08IL-2\uff09\u524d\u836f\u878d\u5408\u86cb\u767d\u3002 AceLink Therapeutics\u53d1\u5e03\u5065\u5eb7\u5fd7\u613f\u8005\u53c2\u4e0e\u8bc4\u4f30AL01211\u7684I\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6570\u636e \u7ebd\u74e6\u514b\uff0c\u52a0\u5229\u798f\u5c3c\u4e9a\u5dde\u2014\u20142024\u5e742\u670826\u65e5\uff0cAceLink Therapeutics\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u5f00\u53d1\u4e0b\u4e00\u4ee3\u53e3\u670d\u5e95\u7269\u51cf\u5c11\u7597\u6cd5\uff08SRTs\uff09\u7684\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8\u5ba3\u5e03\uff0c\u5176\u5728\u5065\u5eb7\u5fd7\u613f\u8005\u4e2d\u8fdb\u884c\u7684AL01211\u7684I\u671f\u7814\u7a76\u7684\u7ed3\u679c\u5df2\u7ecf\u53d1\u8868\u5728\u540c\u884c\u8bc4\u5ba1\u7684\u7f8e\u56fd\u4e34\u5e8a\u836f\u5b66\u9662\u671f\u520a\u300aClinical Pharmacology in Drug Development\u300b\u4e0a\u3002AL01211\u662f\u4e00\u79cd\u5f3a\u5927\u7684\u53e3\u670d\u8461\u7cd6\u795e\u7ecf\u9170\u80fa\u5408\u6210\u9176\uff08GCS\uff09\u6291\u5236\u5242\uff0c\u6b63\u5728\u5f00\u53d1\u7528\u4e8e\u6cbb\u7597\u6cd5\u5e03\u91cc\u75c5\u548cI\u578b\u6208\u8c22\u75c5\u3002 \u5728\u5df2\u53d1\u8868\u7684I\u671f\u7814\u7a76\u4e2d\uff0c\u5bf9AL01211\u8fdb\u884c\u4e86\u5355\u5242\u91cf\u9012\u589e\u548c\u591a\u5242\u91cf\u9012\u589e\u7684\u7814\u7a76\uff0c\u4ee5\u786e\u5b9a\u5176\u5728\u5065\u5eb7\u5fd7\u613f\u8005\u4e2d\u7684\u5b89\u5168\u6027\u3001\u836f\u4ee3\u52a8\u529b\u5b66\uff08PK\uff09\u548c\u836f\u6548\u5b66\uff08PD\uff09\u6548\u5e94\u3002\u603b\u4f53\u800c\u8a00\uff0cAL01211\u5177\u6709\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\uff0c\u65e0\u4e25\u91cd\u4e0d\u826f\u4e8b\u4ef6\u3002\u572830mg\u5242\u91cf\u6c34\u5e73\u4e0b\uff0c\u8840\u6d46\u8461\u7cd6\u57fa\u795e\u7ecf\u9170\u80fa\u548c\u7403\u86cb\u767d\u4e09\u7cd6\u795e\u7ecf\u9170\u80fa\u5206\u522b\u4ece\u57fa\u7ebf\u6c34\u5e73\u964d\u4f4e\u4e8678%\u548c52%\uff0c\u4ece\u800c\u652f\u6301AL01211\u7684\u8fdb\u4e00\u6b65\u4e34\u5e8a\u7814\u7a76\u3002 Basking\u5ba3\u5e03\u5b8c\u6210\u7531ARCH\u9886\u6295\u76845500\u4e07\u7f8e\u5143\u878d\u8d44\uff0c\u52a0\u901f\u53ef\u9006\u6eb6\u6813\u5242\u7684\u4e34\u5e8a\u5f00\u53d1 \u4fc4\u4ea5\u4fc4\u5dde\u54e5\u4f26\u5e03\u2014\u20142024\u5e741\u670830\u65e5\uff0cBasking Biosciences\uff08\u4ee5\u4e0b\u7b80\u79f0&quot;Basking&quot;\uff09\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\uff0c\u4e00\u5bb6\u5f00\u53d1\u65b0\u578b\u6025\u6027\u6eb6\u6813\u7597\u6cd5\u6cbb\u7597\u5352\u4e2d\u7684\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8\uff0c\u5ba3\u5e03\u5b8c\u62105500\u4e07\u7f8e\u5143\u7684\u878d\u8d44\u3002\u65b0\u6295\u8d44\u8005ARCH Venture Partners\u9886\u6295\uff0c\u5176\u4ed6\u65b0\u6295\u8d44\u8005Insight Partners\u3001Platanus\u3001Solas BioVentures\u548cRTW Investments\uff0c\u4ee5\u53ca\u73b0\u6709\u6295\u8d44\u8005\u8ddf\u6295\u3002ARCH Venture Partners\u8463\u4e8b\u603b\u7ecf\u7406Steven Gillis\u535a\u58eb\u5c06\u62c5\u4efbBasking\u8463\u4e8b\u4f1a\u4e3b\u5e2d\u3002\u6b64\u524d\u516c\u53f8\u66fe\u5b8c\u6210540\u4e07\u7f8e\u5143\u79cd\u5b50\u8f6e\u878d\u8d44\uff0c\u6295\u8d44\u8005\u5305\u62ecRev1 Ventures\u3001Broadview Ventures\u548c\u7ef4\u4e9a\u751f\u7269\u3002 Basking\u5c06\u5229\u7528\u878d\u8d44\u52a0\u901fBB-031\u7684\u4e34\u5e8a\u5f00\u53d1\u3002\u8fd9\u662f\u4e00\u79cd\u9776\u5411von Willebrand\u56e0\u5b50\uff08vWF\uff09\u7684\u540c\u7c7b\u9996\u521b\u53ef\u9006RNA aptamers\uff0c\u4e13\u4e3a\u5feb\u901f\u8d77\u6548\u548c\u77ed\u6301\u7eed\u65f6\u95f4\u7684\u7597\u6548\u800c\u8bbe\u8ba1\u3002 \u7279\u79d1\u7f57\u83b7\u4e07\u7269\u521b\u6295\u6570\u767e\u4e07\u7f8e\u5143Pre-B\u8f6e\u878d\u8d44\uff0c\u4e14\u5176\u6cbb\u7597\u96c4\u6fc0\u7d20\u6027\u8131\u53d1\u5168\u7403\u9996\u521b\u65b0\u836fTDM-105795\u4e34\u5e8a\u4e8c\u671fa\u8bd5\u9a8c\u987a\u5229\u5b8c\u6210\u53ca\u5b8c\u6210\u9488\u5bf9\u6e7f\u75b9\/\u76ae\u708e\u9002\u5e94\u75c7\u7684TDM-180935\u5242\u91cf\u9012\u589e\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c \u636e\u52a8\u8109\u7f511\u670815\u65e5\u6d88\u606f\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u3001\u4e00\u5bb6\u4e13\u6ce8\u76ae\u80a4\u75be\u75c5\u65b0\u836f\u7814\u53d1\u7684\u4e34\u5e8a\u9636\u6bb5\u516c\u53f8\u7279\u79d1\u7f57\u751f\u7269\u79d1\u6280\uff08\u6210\u90fd\uff09\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7b80\u79f0&quot;\u7279\u79d1\u7f57&quot;\uff09\uff0c\u5ba3\u5e03\u5df2\u4e8e\u8fd1\u671f\u5b8c\u6210\u6570\u5343\u4e07\u4eba\u6c11\u5e01\u7684Pre-B\u8f6e\u878d\u8d44\uff0c\u672c\u8f6e\u878d\u8d44\u6295\u8d44\u65b9\u4e3a\u4e07\u7269\u521b\u6295\uff0c\u6240\u878d\u8d44\u91d1\u5c06\u7528\u4e8e\u6bdb\u53d1\u9879\u76ee\u7684\u540e\u7eed\u4e34\u5e8a\u5f00\u53d1\u548c\u6e7f\u75b9\u76ae\u708e\u9879\u76ee\u4e2d\u7f8e\u53cc\u62a5\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff08\u4e2d\u7f8eIIa\u4e34\u5e8a\uff09\u3002\u968f\u540e2\u67085\u65e5\uff0c\u7279\u79d1\u7f57\u5f88\u9ad8\u5174\u5730\u5ba3\u5e03\uff1a\u5916\u7528\u6d82\u62b9\u5236\u5242TDM-105795\u7528\u4e8e\u6cbb\u7597\u96c4\u6fc0\u7d20\u6027\u8131\u53d1\uff08AGA\uff09\u7684\u9996\u4e2a\u4e34\u5e8a\u4e8c\u671f\u8bd5\u9a8c\uff08NCT05802173\uff09\u987a\u5229\u5b8c\u6210\u3002 \u6b64\u5916\uff0c2023\u5e7412\u67084\u65e5\uff0c\u7279\u79d1\u7f57\u5ba3\u5e03\u5df2\u7ecf\u5b8c\u6210\u9488\u5bf9\u7279\u5e94\u6027\u76ae\u708e\/\u6e7f\u75b9\u7684TDM-180935\u5916\u7528\u8f6f\u818f\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff08NCT05525468\uff09\uff0c\u8bd5\u9a8c\u7ed3\u679c\u5747\u8fbe\u5230\u9884\u671f\u3002 \u8f90\u8054\u79d1\u6280\u5ba3\u5e03\u5b8c\u6210B\u8f6e\u7f8e\u5143\u878d\u8d44\uff0c\u4e14\u5176\u6bd4\u5229\u65f6GMP\u751f\u4ea7\u8bbe\u65bd\u5960\u57fa 2024\u5e741\u67084\u65e5\uff0c\u4e0a\u6d77\/\u8ba9\u5e03\u5362\/\u6d77\u5fb7\u5821\u2014\u2014\u7ef4\u4e9a\u751f\u7269\u88ab\u6295\u4f01\u4e1a\u3001\u5168\u9762\u6574\u5408\u7684\u56fd\u9645\u5316\u653e\u5c04\u6027\u836f\u7269\u6cbb\u7597\u516c\u53f8\u8f90\u8054\u79d1\u6280\u6709\u9650\u516c\u53f8\uff08\u4ee5\u4e0b\u7b80\u79f0&quot;\u8f90\u8054\u79d1\u6280&quot;\uff09\uff0c\u5ba3\u5e03\u5b8c\u62106330\u4e07\u7f8e\u5143\u878d\u8d44\uff0c\u5176\u4e2d\u5305\u62ec4730\u4e07\u7f8e\u5143\u7684B\u8f6e\u80a1\u6743\u878d\u8d44\u548c1600\u4e07\u7f8e\u5143\u7684\u6388\u4fe1\u989d\u5ea6\u3002\u672c\u6b21\u878d\u8d44\u5c06\u5e2e\u52a9\u516c\u53f8\u5feb\u901f\u63a8\u8fdb\u5176\u653e\u5c04\u6027\u836f\u7269\u7ba1\u7ebf\u7684\u5f00\u53d1\u548c\u836f\u7269\u751f\u4ea7\u80fd\u529b\u7684\u5efa\u8bbe\uff0c\u5e76\u4f18\u5316\u5176\u4e13\u6709\u53d1\u73b0\u5e73\u53f0UniRDC&#x2122;\u3002 \u968f\u7740\u672c\u6b21\u878d\u8d44\u7684\u5b8c\u6210\uff0c\u8f90\u8054\u79d1\u6280\u81ea2021\u5e748\u6708\u6210\u7acb\u4ee5\u6765\u5df2\u7d2f\u8ba1\u878d\u8d44\u8d85\u8fc71.1\u4ebf\u7f8e\u5143\uff0c\u5305\u62ec\u80a1\u6743\u878d\u8d44\u3001\u503a\u6743\u878d\u8d44\u548c\u653f\u5e9c\u8865\u8d34\u3002 \u6b64\u524d12\u67088\u65e5\uff0c\u8f90\u8054\u79d1\u6280\u8fd8\u5ba3\u5e03\u4e86\u5728\u6bd4\u5229\u65f6\u8ba9\u5e03\u5362\u5e02\u5f00\u5de5\u5efa\u8bbe\u5176\u7b26\u5408\u751f\u4ea7\u8d28\u91cf\u7ba1\u7406\u89c4\u8303\uff08&quot;GMP&quot;\uff09\u7684\u653e\u5c04\u6027\u836f\u7269\u751f\u4ea7\u8bbe\u65bd\uff0c\u4ee5\u8fdb\u4e00\u6b65\u63a8\u8fdb\u653e\u5c04\u6027\u836f\u7269\u7684\u5168\u4ea7\u4e1a\u94fe\u89e3\u51b3\u65b9\u6848\u3002 \u7ef4\u7738\u751f\u7269\u83b7\u9999\u6e2f\u521b\u65b0\u79d1\u6280\u7f72&quot;\u4f01\u4e1a\u652f\u63f4\u8ba1\u5212&quot;\u8d44\u52a9\uff0c\u4e14\u8363\u767b\u300a2023\u80e1\u6da6\u5168\u7403\u730e\u8c79\u4f01\u4e1a\u699c\u300b \u8fd1\u671f\uff0c\u7531\u7ef4\u4e9a\u751f\u7269\u53c2\u4e0e\u6295\u8d44\u5b75\u5316\u7684\u7ef4\u7738\u751f\u7269\u7684\u9999\u6e2f\u5b50\u516c\u53f8\uff0c\u4e00\u5bb6\u805a\u7126\u5dee\u5f02\u5316\u548c\u5168\u7403\u65b0\u5f00\u53d1\u7684\u773c\u79d1\u521b\u65b0\u836f\u516c\u53f8\uff0c\u5ba3\u5e03\u5176\u521b\u65b0\u773c\u5e95\u836f\u7269VVN481\u6210\u529f\u83b7\u5f97\u9999\u6e2f\u521b\u65b0\u79d1\u6280\u7f72&quot;\u4f01\u4e1a\u652f\u63f4\u8ba1\u5212Enterprise Support Scheme&quot;(ESS\u2014Hong Kong-Israel R&amp;D Cooperation Programme) \u8d44\u52a9\u3002\u6b64\u6b21\u8d44\u52a9\u5c06\u7528\u4e8e\u63a8\u8fdb\u8be5\u7ba1\u7ebf\u7684\u4e34\u5e8a\u524d\u7814\u53d1\u5de5\u4f5c\uff0c\u4ee5\u671f\u66f4\u5feb\u63a8\u8fdb\u5230\u4e34\u5e8a\u9636\u6bb5\u3002\u6b64\u5916\uff0c\u8fd1\u65e5\u7ef4\u7738\u751f\u7269\u8fd8\u8363\u767b\u300a2023\u80e1\u6da6\u5168\u7403\u730e\u8c79\u4f01\u4e1a\u699c\u300b\u3002 \u7ef4\u4e9a\u751f\u7269\u88ab\u6295\u4f01\u4e1aAbsci\u5ba3\u5e03\u4e0e\u963f\u65af\u5229\u5eb7\u5408\u4f5c\u5f00\u53d1\u4eba\u5de5\u667a\u80fd\u9a71\u52a8\u7684\u80bf\u7624\u5019\u9009\u836f\u7269 \u534e\u76db\u987f\u5dde\u6e29\u54e5\u534e\uff0c2023\u5e7412\u67084\u65e5\u2014\u2014\u7ef4\u4e9a\u751f\u7269\u88ab\u6295\u4f01\u4e1a\u3001\u751f\u6210\u5f0f\u4eba\u5de5\u667a\u80fd\u6297\u4f53\u53d1\u73b0\u9886\u57df\u7684\u9886\u5bfc\u8005Absci\u516c\u53f8\uff08NASDAQ:ABSI\uff09\uff0c\u5ba3\u5e03\u4e0e\u5168\u7403\u751f\u7269\u5236\u836f\u516c\u53f8\u963f\u65af\u5229\u5eb7\uff08AstraZeneca\uff09\u5408\u4f5c\uff0c\u9488\u5bf9\u80bf\u7624\u9776\u70b9\u63d0\u4f9b\u4eba\u5de5\u667a\u80fd\u8bbe\u8ba1\u7684\u6297\u4f53\u3002\u6b64\u6b21\u5408\u4f5c\u5c06Absci\u7684Integrated Drug Creation&#x2122;\u5e73\u53f0\u4e0e\u963f\u65af\u5229\u5eb7\u5728\u80bf\u7624\u5b66\u9886\u57df\u7684\u4e13\u4e1a\u77e5\u8bc6\u76f8\u7ed3\u5408\uff0c\u65e8\u5728\u52a0\u901f\u53d1\u73b0\u6f5c\u5728\u7684\u65b0\u578b\u764c\u75c7\u6cbb\u7597\u5019\u9009\u836f\u7269\u3002\u636e\u6089\uff0c\u8be5\u534f\u8bae\u5305\u62ec\u9884\u4ed8\u6b3e\u3001\u7814\u53d1\u7ecf\u8d39\u548c\u91cc\u7a0b\u7891\u6b3e\u9879\u7b49\uff0c\u603b\u91d1\u989d\u9ad8\u8fbe2.47\u4ebf\u7f8e\u5143\u3002 \u5173\u4e8e\u535a\u81f4\u751f\u7269 \u535a\u81f4\u751f\u7269\u521b\u7acb\u4e8e2019\u5e74\uff0c\u7531\u86cb\u767d\u8d28\u5de5\u7a0b\u548c\u80bf\u7624\u514d\u75ab\u9886\u57df\u7684\u9876\u5c16\u4e13\u5bb6\u56e2\u961f\u7ec4\u5efa\uff0c\u81f4\u529b\u4e8e\u5f00\u53d1\u65b0\u4e00\u4ee3\u7ec6\u80de\u56e0\u5b50\u6297\u80bf\u7624\u514d\u75ab\u7597\u6cd5\u3002\u516c\u53f8\u81ea\u4e3b\u7814\u53d1\u4e86&quot;Crossover&quot;\u524d\u836f\u6280\u672f\u5e73\u53f0\uff0c\u80fd\u5b9e\u73b0\u7ec6\u80de\u56e0\u5b50\u5728\u80bf\u7624\u5fae\u73af\u5883\u4e2d\u7279\u5f02\u6027\u91ca\u653e\uff0c\u6709\u6548\u89e3\u51b3\u4e86\u7ec6\u80de\u56e0\u5b50\u7684\u5916\u5468\u6bd2\u6027\u95ee\u9898\u3002\u4f9d\u6258\u8be5\u5e73\u53f0\u6280\u672f\uff0c\u516c\u53f8\u6210\u529f\u5f00\u53d1\u4e86\u4e34\u5e8a\u5019\u9009\u836f\u7269PTX-912\uff0c\u5df2\u7ecf\u542f\u52a8\u7f8e\u56fd1\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002&hellip; <a class=\"read-more\" href=\"https:\/\/www.xinwengao.com\/cn\/pr\/20240306182400106977\">Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":0,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-106977","post","type-post","status-publish","format-standard","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/106977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=106977"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/106977\/revisions"}],"predecessor-version":[{"id":106978,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/106977\/revisions\/106978"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=106977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=106977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=106977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}